The regenerative medicine market in Japan is forecasted to grow by USD 4600.6 million during 2024-2029, accelerating at a CAGR of 21.2% during the forecast period. The report on the regenerative medicine market in Japan provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of STEM cell therapy, rising prevalence of chronic diseases, and increasing aging population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Market Scope
Base Year
2025
End Year
2029
Series Year
2025-2029
Growth Momentum
Accelerate
YOY 2025
17.3%
CAGR
21.2%
Incremental Value
$4600.6 mn
Technavio's regenerative medicine market in Japan is segmented as below:
By Application
Oncology
Musculoskeletal
Dermatology
Others
By Technology
Cell and tissue-based
Gene therapy
By End-user
Hospitals and clinics
Speciality centers
Government and research institutes
By Geographical Landscape
APAC
This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market in Japan growth during the next few years. Also, growing mergers and acquisitions among companies and development of induced pluripotent STEM cells will lead to sizable demand in the market.
The report on the regenerative medicine market in Japan covers the following areas:
Regenerative Medicine Market in Japan sizing
Regenerative Medicine Market in Japan forecast
Regenerative Medicine Market in Japan industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market in Japan vendors that include Astellas Pharma Inc., Becton Dickinson and Co., CellSeed Inc., Cellusion Inc., Cyfuse Biomedical K.K., F. Hoffmann La Roche Ltd., FUJIFILM Holdings Corp., iHeart Japan Corp., Japan Tissue Engineering Co. Ltd., JCR Pharmaceticals Co. Ltd., Nikon Corp., ROHTO Pharmaceutical Co. Ltd., Sumitomo Pharma Co. Ltd., Takara Bio Inc., Takeda Pharmaceutical Co. Ltd., Terumo Corp., and Yokogawa Electric Corp.. Also, the regenerative medicine market in Japan analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Technology
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan: Year-over-year growth 2024-2029 (%)
Data Table on Japan: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Regenerative Medicine Market in Japan 2019 - 2023
Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2019 - 2023 ($ million)